Villanova Investment Management Co LLC Increases Stock Position in Ingevity Co. (NYSE:NGVT)

Villanova Investment Management Co LLC raised its position in Ingevity Co. (NYSE:NGVT) by 17.8% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 57,104 shares of the company’s stock after buying an additional 8,645 shares during the period. Ingevity comprises 2.1% of Villanova Investment Management Co LLC’s investment portfolio, making the stock its 17th biggest position. Villanova Investment Management Co LLC owned approximately 0.16% of Ingevity worth $2,327,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Wellington Management Group LLP raised its holdings in Ingevity by 5.4% in the 4th quarter. Wellington Management Group LLP now owns 2,239,970 shares of the company’s stock worth $91,279,000 after purchasing an additional 115,581 shares during the period. State Street Corp raised its stake in shares of Ingevity by 14.7% during the 3rd quarter. State Street Corp now owns 1,546,957 shares of the company’s stock worth $60,331,000 after buying an additional 198,300 shares during the period. American Century Companies Inc. lifted its position in shares of Ingevity by 37.7% during the 4th quarter. American Century Companies Inc. now owns 1,457,365 shares of the company’s stock valued at $59,388,000 after buying an additional 398,800 shares in the last quarter. Segall Bryant & Hamill LLC grew its stake in Ingevity by 8.6% in the 4th quarter. Segall Bryant & Hamill LLC now owns 1,287,281 shares of the company’s stock valued at $52,457,000 after acquiring an additional 101,866 shares during the period. Finally, Royce & Associates LP grew its stake in Ingevity by 22.4% in the 4th quarter. Royce & Associates LP now owns 1,142,598 shares of the company’s stock valued at $46,561,000 after acquiring an additional 208,921 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Analysts Set New Price Targets

NGVT has been the topic of several recent analyst reports. BMO Capital Markets raised shares of Ingevity from a “market perform” rating to an “outperform” rating and increased their price objective for the company from $62.00 to $65.00 in a report on Wednesday, February 26th. StockNews.com lowered shares of Ingevity from a “buy” rating to a “hold” rating in a research note on Monday, March 24th. Three analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, Ingevity has an average rating of “Moderate Buy” and an average target price of $55.17.

Ingevity Stock Up 0.0 %

NGVT stock opened at $39.64 on Tuesday. The company has a current ratio of 1.87, a quick ratio of 1.04 and a debt-to-equity ratio of 6.86. The firm has a 50-day moving average of $45.01 and a two-hundred day moving average of $42.63. Ingevity Co. has a 12 month low of $30.90 and a 12 month high of $56.30. The company has a market cap of $1.44 billion, a price-to-earnings ratio of -3.35 and a beta of 1.53.

Ingevity (NYSE:NGVT) last posted its quarterly earnings results on Tuesday, February 18th. The company reported $0.95 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.29 by $0.66. The business had revenue of $298.80 million during the quarter, compared to analyst estimates of $297.40 million. Ingevity had a positive return on equity of 41.44% and a negative net margin of 30.60%. As a group, analysts forecast that Ingevity Co. will post 4.45 earnings per share for the current fiscal year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.